Extra-adrenal induction of Cyp21a1 ameliorates systemic steroid metabolism in a mouse model of congenital adrenal hyperplasia
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Congenital adrenal hyperplasia (CAH) due to steroid 21-hydroxylase (21-OH) deficiency (21-OHD) is an autosomal recessive disorder, in which CYP21A2 mutations or deletions result in underproduction of glucocorticoid and mineralocorticoid, and overproduction of androgens. Patients with CAH are treated with oral steroid supplementation, but optimal control of blood steroid levels remains difficult. Thus, new therapeutic approaches are still needed. Previously, adenovirus-mediated administration of human CYP21A2 to adrenal glands rescued the phenotype of a mouse model of 21-OHD. In this study, we examined whether transduction of murine Cyp21a1 in extra-adrenal tissues could rescue steroid metabolism in 21-OHD mice. We transduced primary fibroblasts obtained from 21-OHD mice with a retroviral vector containing Cyp21a1. In vitro assays demonstrated that Cyp21a1-expressing fibroblasts can uptake progesterone from the culture media, convert it to deoxycorticosterone (DOC), and subsequently release DOC back into the media. Autotransplantation of Cyp21a1-expressing fibroblasts into the subcutaneous tissues of the back resulted in a significant reduction in the serum progesterone/DOC ratio in four of six 21-OHD mice at 4 weeks after injection. We also directly injected an adeno-associated viral vector containing Cyp21a1 into the thigh muscles of 21-OHD mice. Serum progesterone/DOC ratios were markedly reduced in all four animals at 4 weeks after injection. These results indicate that extra-adrenal induction of Cyp21a1 ameliorates steroid metabolism in 21-OHD mice. This study suggests a novel therapeutic strategy for congenital adrenal hyperplasia, which warrants further investigations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mice bearing a deletion of approximately 80 kilobases of chromosome 17 (516), including the Cyp21 locus showed perinatal lethality, elevated ACTH, cortical hyperplasia with lack of proper zonation, accumulation of steroid precursors and both glucocorticoid and mineralocorticoid deficiency (517).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [516]
Experimental — accuracy not yet measuredIn the citing paper
“Intramuscular injection of an AAV vector with mouse Cyp21a1 in CAH mice resulted in enzyme expression for more than 6 months162.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [162]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Congenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges
Mingozzi, F., & High, K. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2988 · Cited by 893
Engineering adeno-associated viruses for clinical gene therapy
Kotterman, M. A., & Schaffer, D. V. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3742 · Cited by 761
State-of-the-art gene-based therapies: the road ahead
Kay, M. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2971 · Cited by 666
Minireview: Regulation of Steroidogenesis by Electron Transfer
Miller, W. L. (2005) · Endocrinology · doi:10.1210/en.2005-0096 · Cited by 324
Carpentier, A. C., Frisch, F., Labbé, S. M., Gagnon, R., de Wal, J., Greentree, S., Petry, H., Twisk, J., Brisson, D., & Gaudet, D. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3002 · Cited by 165
Speiser, P. W., Agdere, L., Ueshiba, H., White, P. C., & New, M. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101173240302 · Cited by 106
Yamashita, K., Miyashiro, Y., Maekubo, H., Okuyama, M., Honma, S., Takahashi, M., & Numazawa, M. (2009) · Steroids · doi:10.1016/j.steroids.2009.06.007 · Cited by 102
Cited by
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Management challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Disorders of Sex Development of Adrenal Origin
Finkielstain, G. P., Vieites, A., Bergadá, I., & Rey, R. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.770782 · Cited by 67
“An alternative strategy is gene therapy, which was tested in mice with a deletion encompassing the Cyp21 locus who received an injection of a replication-deficient adenovirus containing the mouse gene extra-adrenally (85), or the human CYP21A2 gene intra-adrenally (86) or intravenously (87).”
MethodClinical advances in the pharmacotherapy of congenital adrenal hyperplasia
Prete, A., Auchus, R. J., & Ross, R. J. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0794 · Cited by 62
Perdomini, M., Dos Santos, C., Goumeaux, C., Blouin, V, & Bougnères, P. (2017) · Gene Therapy · doi:10.1038/gt.2017.10 · Cited by 37
The adrenal gland microenvironment in health, disease and during regeneration
Kanczkowski, W., Sue, M., & Bornstein, S. R. (2017) · HORMONES · doi:10.14310/horm.2002.1744 · Cited by 41
Novel treatments for congenital adrenal hyperplasia
Schröder, M. A. M., & der Grinten, H. L. C. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09717-w · Cited by 35
“Preclinical studies have demonstrated promising results; a single intraadrenal injection or less invasive intra-muscular injection of an adenoviral vector encoding CYP21A2/CYP21A1 in 21OHD mice successfully induced CYP21 expression and resulted in corticosterone production at similar levels as observed in wild-type mi…”
White, P. C. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000402 · Cited by 29
Ilagan, Y., Mamillapalli, R., Goetz, T. G., Kayani, J., & Taylor, H. S. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2017.05.001 · Cited by 28
“Cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in the synthesis of cholesterol, steroids and other lipids [79].”
BackgroundCharkoftaki, G., Chen, Y., Han, M., Sandoval, M., Yu, X., Zhao, H., Orlicky, D. J., Thompson, D. C., & Vasiliou, V. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.02.013 · Cited by 23
Future Directions for Adrenal Insufficiency: Cellular Transplantation and Genetic Therapies
Graves, L. E., Torpy, D. J., Coates, P. T., Alexander, I. E., Bornstein, S. R., & Clarke, B. M. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac751 · Cited by 24
You, Z., Yuan, J., Wang, Y., Sun, Y., Ni, A., Li, Y., Ma, H., Ma, T., & Chen, J. (2024) · Poultry Science · doi:10.1016/j.psj.2024.103589 · Cited by 21
“Extra-adrenal induction of CYP21A1 could ameliorate steroid metabolism (Naiki et al., 2016).”
BackgroundSarafoglou, K., & Auchus, R. J. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae759 · Cited by 23
“…induced CYP21A2 expression in the adrenal cortex and reduced progesterone levels for over 15 weeks (96), and intramuscular injection of an AAV-based Cyp21a1 transgene achieved long-lasting extra-adrenal enzyme expression, with reduced progesterone levels that were sustained through 7 months (97).”
Emerging medical therapies for congenital adrenal hyperplasia
Speiser, P. (2019) · F1000Research · doi:10.12688/f1000research.17778.1 · Cited by 17
Naiki, Y., Miyado, M., Shindo, M., Horikawa, R., Hasegawa, Y., Katsumata, N., Takada, S., Akutsu, H., Onodera, M., & Fukami, M. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.005 · Cited by 13
Self-citationGraves, L. E., van Dijk, E. B., Zhu, E., Koyyalamudi, S. R., Wotton, T., Sung, D., Srinivasan, S., Ginn, S. L., & Alexander, I. E. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101232 · Cited by 15
“48 20, 49 While one group demonstrated a positive effect on the Cyp21a1 (cid:1) / While human clinical translation is plausible, the approach described would require re fi nement.”
BackgroundTowards novel treatments for adrenal diseases: Cell- and gene therapy-based approaches
Mariniello, K., & Guasti, L. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111160 · Cited by 11
Kendırcı, H. N. P., Ünal, E., Dündar, İ., Buluş, A. D., Güneş, S. O., & Şıklar, Z. (2024) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2024.2024-6-26-s · Cited by 11
“Intra-adrenal injection of viruses carrying the human CYP21A2 gene reversed the CAH-like phenotype for 40 days (70,71).”
Okpaise, O. O., Ahn, H., Tonni, G., & Ruano, R. (2024) · Prenatal Diagnosis · doi:10.1002/pd.6542 · Cited by 10
“In another study, Naiki et al. 66 have also documented that transduced fibroblasts could produce 21 - OHD in mice, and this technique could be applied to enhance human therapy, although the function of 21 - OHD is not entirely compatible with the human enzyme system.”
BackgroundGenome editing in the adrenal gland: a novel strategy for treating congenital adrenal hyperplasia
van Dijk, E. B., Ginn, S. L., Alexander, I. E., & Graves, L. E. (2024) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2024.00011 · Cited by 8
Speiser, P., Auchus, R. J., Merke, D. P., Miller, W. L., & White, P. C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02629 · Cited by 8
Monteiro, A. S. P. D. R., Pavithran, P. V., Puthukulangara, M., Bhavani, N., Nampoothiri, S., Yesodharan, D., & Kumaran, R. (2023) · HORMONES · doi:10.1007/s42000-023-00445-7 · Cited by 7
Huang, Y., Liang, M., Liao, Y., Ji, Z., Lin, W., Pu, X., Wang, L., & Wang, W. (2024) · Metabolites · doi:10.3390/metabo14090509 · Cited by 6
“The expression and activity changes displayed by CYP21A1 contribute to the synthesis and secretion of steroid hormones [36,37].”
BackgroundChallenges in managing disorders of sex development associated with adrenal dysfunction
Finkielstain, G. P., & Rey, R. A. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2256393 · Cited by 6
Graves, L. E., Viswanath, L., van Dijk, E. B., Zhu, E., Koyyalamudi, S. R., Wotton, T., Rosser, S. P. A., Srinivasan, S., Ginn, S. L., & Alexander, I. E. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.11.011 · Cited by 4
Approach to the Child and Adolescent With Adrenal Insufficiency
Patti, G., Zucconi, A., Matarese, S., Tedesco, C., Panciroli, M., Napoli, F., Iorgi, N. D., & Maghnie, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae564 · Cited by 5
Updated Gene Therapy for Renal Inborn Errors of Metabolism
Hergenrother, S. R., Husein, M., Thompson, C., Kalina, E., & Raina, R. (2025) · Genes · doi:10.3390/genes16050516 · Cited by 3
Ravichandran, L., Asha, H. S., Mathai, S., Thomas, N., & Chapla, A. (2024) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_303_23 · Cited by 3
“OH in mice, [81] which can temporarily enhance glucocorticoid and mineralocorticoid hormone synthesis.”
BackgroundBacila, I. A., Oberski, L., Li, N., Storbeck, K., Cunliffe, V. T., & Krone, N. P. (2025) · Biology Open · doi:10.1242/bio.061977 · Cited by 3
“Previous studies using Cyp21a2 − / − mouse models (Gotoh et al., 1988, 1994; Naiki et al., 2016; Thirumalasetty et al., 2024) reported decreased weight in mutants.”
Exploration of the potential of genomic editing in the treatment of congenital adrenal hyperplasia
Graves, L. E., Christina, S., Mullany, K., Alexander, I. E., & Falhammar, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1719376 · Cited by 2
Gene and cell therapy of adrenal pathology: achievements and prospects
Glazova, O., Vorontsova, M. V., Sakr, N., Shevkova, L., Onyanov, N., Kaziakhmedova, S., & Volchkov, P. (2021) · Problems of Endocrinology · doi:10.14341/probl12818 · Cited by 2
Liu, M., Su, F., He, Y., Sun, M., Bai, C.-X., Zhang, W., Li, B., Sun, Y., Wang, Q., & Kuang, H. (2025) · Foods · doi:10.3390/foods14172945 · Cited by 2
“Similarly, steroid hormones, including glucocorticoids, are key regulators of metabolic homeostasis [25].”
Corticosteroid Replacement Therapy
Onyema, M. C. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98803 · Cited by 2
Naiki, Y., & Fukami, M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02529 · Cited by 2
Self-citationCurrent and future perspectives on clinical management of classic 21-hydroxylase deficiency
Yogi, A., & Kashimada, K. (2023) · Endocrine Journal · doi:10.1507/endocrj.ej23-0075 · Cited by 2
Ouyang, Q., Song, Y., Li, J., Xiao, J., Song, Z., Zhang, H., & He, X. (2026) · Food Chemistry Molecular Sciences · doi:10.1016/j.fochms.2026.100366 · Cited by 1
“The role of CYP21A1 extends beyond its classical association with cortico-steroid synthesis.”
InfluentialHonour, J. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818124-9.00012-7
de la Perrière, A. B., & Martinerie, L. (2026) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2026.01.004
Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia
Goai, W. H., & Torpy, D. J. (2026) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2026.2695099
“Extra-adrenal gene delivery via intramuscular injection of the AAV vector with murine Cyp21a1 led to a non-significant reduction in the serum progesterone/deoxycorticosterone ratio for up to 7 months [100].”
Metadata
- Authors
- Naiki, Y., Miyado, M., Horikawa, R., Katsumata, N., Onodera, M., Pang, S., Ogata, T., & Fukami, M.
- Affiliations
- National Center For Child Health and Development (JP)
- National Research Institute for Child Health and Development (JP)
- University of Illinois Chicago (US)
- Hamamatsu University School of Medicine (JP)
- ORCID
- Venue
- Endocrine Journal
- Publisher
- Japan Endocrine Society
- Published
- 2016
- Volume
- 63
- Issue
- 10
- Pages
- 897-904
- ISSN
- 0918-8959 (ISSN-L)
- 1348-4540
- OpenAlex
- W2461136111
- Cited by
- 40
- References
- 19
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 9 · 2023: 5 · 2022: 4 · 2021: 5 · 2019: 1 · 2018: 3 · 2017: 5
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Endocrine Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Center for Child Health and Development
- Research Organization of Information and Systems
- Japan Society for the Promotion of Science (22591148, 16K10005, 25461575)
- Institute of Genetics
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, deoxycorticosterone, progesterone, adeno-associated virus gene therapy, retroviral vectors, autologous transplantation, fibroblasts, steroid metabolism, mouse model
- MeSH terms
- Adrenal Hyperplasia, Congenital, Animals, Disease Models, Animal, Female, Glucocorticoids, Humans, Mice, Inbred C57BL, Mice, Transgenic, Steroid 21-Hydroxylase, Genetic Therapy, Up-Regulation, Gene Transfer Techniques, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.